Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human ANGPTL7 ELISA Kit (AC2991)
Cat.#: ASET-1580
Specifications
Description Human ANGPTL7 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human ANGPTL7 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.046 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1513 Human APLNR ELISA Kit (AC2924) Quantitative inquiry ASET-1600 Human LAMP1 ELISA Kit (AC3011) Quantitative inquiry ASET-1047 Human GAPDH ELISA Kit (AC2458) Quantitative inquiry ASET-1393 Human Synaptophysin ELISA Kit (AC2804) Quantitative inquiry ASET-2506 Bovine Antidiuretic Hormone ELISA Kit (AC3917) Quantitative inquiry ASET-2339 Human Cathepsin B ELISA Kit (AC3750) Quantitative inquiry ASET-1691 Human Aldolase C ELISA Kit (AC3102) Quantitative inquiry ASET-1142 Human SHANK3 ELISA Kit (AC2553) Quantitative inquiry ASET-1146 Human Urocortin ELISA Kit (AC2557) Quantitative inquiry ASET-2247 Human PON1 ELISA Kit (AC3658) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket